Business · 1 sources covering this

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

Mankind Pharma's consumer healthcare remains a key monitorable, with high-single-digit growth expected in FY27 and recovery anticipated in FY28, adds the brokerage.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price
Mankind Pharma's consumer healthcare remains a key monitorable, with high-single-digit growth expected in FY27 and recovery anticipated in FY28, adds the brokerage.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/45473f6fb1279ab89caaa4938137d5ed1285a085"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price"></iframe>

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

How 1 sources are covering this

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

More from Business

Cyclone Arnab Live Tracker: Andhra Pradesh Coast on Alert; These Districts In Odisha, Jharkhand Districts To Heavy Rain

Thane Water Cut Explained: Timings, Affected Areas and What Residents Should Know

Capital Goods Valuations At Long-Term Average; Earnings To Remain Strong For 4-6 Quarters: PL Capital

SC seeks response on plea alleging Rahul Gandhi pushed pregnant journalist

Reader

Trust & legal

Across the network